CN105079479A - Method for preventing silicosis - Google Patents
Method for preventing silicosis Download PDFInfo
- Publication number
- CN105079479A CN105079479A CN201510564128.5A CN201510564128A CN105079479A CN 105079479 A CN105079479 A CN 105079479A CN 201510564128 A CN201510564128 A CN 201510564128A CN 105079479 A CN105079479 A CN 105079479A
- Authority
- CN
- China
- Prior art keywords
- herba
- parts
- silicosis
- dust
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a method for preventing silicosis. The silicosis belongs to gasp syndrome, cough and lung distension in the traditional Chinese medicine. The disease condition of a patient is worsened gradually due to repeated infection. The disease starts from the lung, then influences the spleen and stomach, and influences the heart in a later period. According to the invention, traditional Chinese medicines comprising adder's tongue herb, cirrhopetalum andersonii, root of waterlilyleaf goldenray, root of false indigo, Chinese mahonia leaf, zornia gibbosa, gynostemma pentaphyllum, scandent schefflera stem and leaf, creeping dichondra herb, cardiospermum halicacabum, ipomoea pes-caprae and juice of vitex negundo are selected to be prepared into decoction, a clinical test result shows that the total effective rate can reach 93.3% which is obviously superior to 66.7% of a control group.
Description
Technical field
Prevention and control of diseases technical field of the present invention, particularly relates to a kind of method of preventing anthraco-silicosis.
Background technology
Anthraco-silicosis is because patient works for a long time in the environment containing higher concentration free silicon dioxide dust, continuous suction silica dust, the phagocytic function of its pulmonary alveolar macrophage is activated, continuous release inflammatory factor and fibrogenic factor and lung tissue is inflamed reaction and Fibrotic a kind of disease.A kind of occupation disease that this Bing Shi China is very common and serious.In recent years, the sickness rate of China's anthraco-silicosis in the trend constantly risen, and still lacks the effective scheme of this disease for the treatment of clinically.Although the Western medicine such as digoxine, hydrochlorothiazide, spironolactone, lotensin, ceftriaxone sodium, clindamycin, levofloxacin, aminophylline achieves certain curative effect in treatment anthraco-silicosis, but more or less can cause side effect, and curative effect is slow and cure no thoroughness, Western medicine is made to have again certain limitation in treatment anthraco-silicosis.
Summary of the invention
The object of this invention is to provide a kind of method of preventing anthraco-silicosis.Anthraco-silicosis belongs to Chinese medicine " the syndrome of dyspnea ", " cough ", " pulmonary distension " category.Because of patient's repeated infection, state of an illness Progressive symmetric erythrokeratodermia is increased the weight of.This disease begins at lung, then affects taste, later stage and the heart.The pathologic products such as expectorant, drink, the stasis of blood can be formed in the course of disease, furthermore demonstrate,prove mutually for specimen, deficiency and excess eventually or affect each other.
The object of the invention is to be achieved through the following technical solutions, the method of this prevention anthraco-silicosis comprises dust-proof, protection, health check-up, rehabilitation, control, described dust-proof, be exactly that the comprehensive dust preventions such as reform production technology, wet operation, airtight dirt source, dust removal by ventilation, plant maintenance maintenance should be grabbed by industrial and mining establishment; Described protection is exactly to production environment periodic monitoring dust in air concentration, and strengthens communication and education; Described health check-up, strengthens having regular physical checkups of silicious dust workman exactly, comprises x-ray rabat, and running time between inspections determines according to contact dioxide-containing silica and air-borne dust concentration; Described rehabilitation, should take to strengthen nutrition and appropriate reconditioning to silicotic exactly, with health invigorating, and the generation of preventing respiratory tract infection and merging symptom; Described control, adopt Chinese herb prevention exactly, described Chinese medicine decoction of preventing and treating anthraco-silicosis is made up of the Chinese medicine of following weight portion: Herba Ophioglossi 7-11 part, Herba Cirrohopetali Andersonii 7-11 part, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 5-9 part, Radix indigoferae Pseudotinctoriae 5-9 part, Folium Mahoniae 9-12 part, Herba Zornia Diphyllae 9-12 part, Herba Gynostemmatis 8-12 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8-12 part, Herba Dichondrae Repentis 8-12 part, Herba Cardiospermi microcarpi 4-8 part, Herba Ipomoeae Pes-Capraes 4-8 part, Sucus Viticis cannabifolia 3-7 part.
Preferred: Herba Ophioglossi 9 parts, Herba Cirrohopetali Andersonii 9 parts, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 7 parts, Radix indigoferae Pseudotinctoriae 7 parts, Folium Mahoniae 10 parts, Herba Zornia Diphyllae 10 parts, Herba Gynostemmatis 10 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10 parts, Herba Dichondrae Repentis 10 parts, Herba Cardiospermi microcarpi 6 parts, Herba Ipomoeae Pes-Capraes 6 parts, Sucus Viticis cannabifolia 5 parts.
Preparation method: above-mentioned Chinese medicine is traditionally made decoction.
Fang Zhong: Herba Ophioglossi heat-clearing and toxic substances removing, promoting blood circulation to remove blood stasis; Herba Cirrohopetali Andersonii is controlled cough, haematemesis, expelling wind and removing dampness, is invigorated blood circulation; Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. relieving cough and resolving phlegm dispels the wind; Radix indigoferae Pseudotinctoriae blood circulation promoting and blood stasis dispelling removing toxic substances; Folium Mahoniae heat clearing away tonify deficiency, relieving cough and resolving phlegm; Herba Zornia Diphyllae heat-clearing and toxic substances removing, blood stasis dispelling; Herba Gynostemmatis eliminating inflammation and expelling toxin, eliminating phlegm and stopping cough; Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) expelling wind and removing dampness, promoting blood circulation and stopping pain, promoting the circulation of QI for relieving swelling; Herba Dichondrae Repentis heat-clearing and toxic substances removing, diuretic are invigorated blood circulation, are regulated the flow of vital energy; Herba Cardiospermi microcarpi heat-clearing and toxic substances removing; Herba Ipomoeae Pes-Capraes expelling wind and removing dampness, medicinal powder for relieving pain are tied; Sucus Viticis cannabifolia except wind heat, reduce phlegm, the meridian dredging, qi and blood circulation promotion.
Clinical data
1, the routine patient of physical data 60 is the outpatient service and inpatient that my institute accepts for medical treatment, according to People's Republic of China's state health standards (GB5906-86) " diagnostic standard of silicosis and treatment principle ", makes a definite diagnosis through x-ray chest film inspection.60 routine patients are divided into treatment group and matched group at random, treatment group 30 example, be male, age 30-56 year, average 45.5 years old, pneumosilicosis course of disease 6-9, average 7.6 years.Matched group 30 example is male, age 33-57 year, average 46 years old, pneumosilicosis course of disease 6.3-9, average 8 years.Two groups of clinical data no significant differences, and have comparability, all pneumosilicosis merger activity pulmonary tuberculosis, pneumothorax, exhale decline, heart failure, spitting of blood person is as the object of observation.
2, Therapeutic Method treatment group takes Chinese medicine decoction of the present invention, its prescription is: Herba Ophioglossi 9 grams, Herba Cirrohopetali Andersonii 9 grams, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 7 grams, Radix indigoferae Pseudotinctoriae 7 grams, Folium Mahoniae 10 grams, Herba Zornia Diphyllae 10 grams, Herba Gynostemmatis 10 grams, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10 grams, Herba Dichondrae Repentis 10 grams, Herba Cardiospermi microcarpi 6 grams, Herba Ipomoeae Pes-Capraes 6 grams, Sucus Viticis cannabifolia 5 grams, be placed in boiling machine and decoct juice, 1 day 1 dose, divide and sooner or later take for 2 times, 10d was 1 course for the treatment of.Matched group takes digoxine 0.125mg ~ 0.25mg, every day 1 time, hydrochlorothiazide 12.5mg ~ 25mg, every day 3 times, quiet of levofloxacin 0.2g, every day 2 times, and aminophylline 0.25g is in 5% Glucose Liquid 250mL iv drip, and every day 1 time, 10d was 1 course for the treatment of.Treat two courses for the treatment of all continuously for two groups, after terminating two courses for the treatment of two groups all row pulmonary function and hematuria conventional, hepatic and renal function, chest film inspection observe clinical symptoms, sign.
3, criterion of therapeutical effect is effective: pant and other transference cure, lab testing is clearly better; Effective: pant and the improvement of other symptom, lab testing is improved; Invalid: cardinal symptom is without improvement or increase the weight of.
4, effective 20 examples in therapeutic outcome treatment group 30 example, effective 8 examples, invalid 2 examples, total effective rate 93.3%; Effective 8 examples in matched group 30 example, effective 12 examples, invalid 10 examples, total effective rate 66.7%, treatment group is evident in efficacy is better than matched group.
Detailed description of the invention
Embodiment one: take Herba Ophioglossi 7 grams, Herba Cirrohopetali Andersonii 7 grams, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 5 grams, Radix indigoferae Pseudotinctoriae 5 grams, Folium Mahoniae 9 grams, Herba Zornia Diphyllae 9 grams, Herba Gynostemmatis 8 grams, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8 grams, Herba Dichondrae Repentis 8 grams, Herba Cardiospermi microcarpi 4 grams, Herba Ipomoeae Pes-Capraes 4 grams, Sucus Viticis cannabifolia 3 grams, be placed in boiling machine and decoct juice, 1 day 1 dose, divide and sooner or later take for 2 times, 10d was 1 course for the treatment of.
Embodiment two: take Herba Ophioglossi 9 grams, Herba Cirrohopetali Andersonii 9 grams, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 7 grams, Radix indigoferae Pseudotinctoriae 7 grams, Folium Mahoniae 10 grams, Herba Zornia Diphyllae 10 grams, Herba Gynostemmatis 10 grams, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10 grams, Herba Dichondrae Repentis 10 grams, Herba Cardiospermi microcarpi 6 grams, Herba Ipomoeae Pes-Capraes 6 grams, Sucus Viticis cannabifolia 5 grams, be placed in boiling machine and decoct juice, 1 day 1 dose, divide and sooner or later take for 2 times, 10d was 1 course for the treatment of.
Embodiment three: take Herba Ophioglossi 11 grams, Herba Cirrohopetali Andersonii 11 grams, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 9 grams, Radix indigoferae Pseudotinctoriae 9 grams, Folium Mahoniae 12 grams, Herba Zornia Diphyllae 12 grams, Herba Gynostemmatis 12 grams, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 12 grams, Herba Dichondrae Repentis 12 grams, Herba Cardiospermi microcarpi 8 grams, Herba Ipomoeae Pes-Capraes 8 grams, Sucus Viticis cannabifolia 7 grams, be placed in boiling machine and decoct juice, 1 day 1 dose, divide and sooner or later take for 2 times, 10d was 1 course for the treatment of.
Claims (2)
1. prevent a method for anthraco-silicosis, comprise dust-proof, protection, health check-up, rehabilitation, control, described dust-proof, be exactly that the comprehensive dust preventions such as reform production technology, wet operation, airtight dirt source, dust removal by ventilation, plant maintenance maintenance should be grabbed by industrial and mining establishment; Described protection is exactly to production environment periodic monitoring dust in air concentration, and strengthens communication and education; Described health check-up, strengthens having regular physical checkups of silicious dust workman exactly, comprises x-ray rabat, and running time between inspections determines according to contact dioxide-containing silica and air-borne dust concentration; Described rehabilitation, should take to strengthen nutrition and appropriate reconditioning to silicotic exactly, with health invigorating, and the generation of preventing respiratory tract infection and merging symptom; Described control, adopt Chinese herb prevention exactly, it is characterized in that described Chinese medicine decoction of preventing and treating anthraco-silicosis is made up of the Chinese medicine of following weight portion: Herba Ophioglossi 7-11 part, Herba Cirrohopetali Andersonii 7-11 part, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 5-9 part, Radix indigoferae Pseudotinctoriae 5-9 part, Folium Mahoniae 9-12 part, Herba Zornia Diphyllae 9-12 part, Herba Gynostemmatis 8-12 part, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 8-12 part, Herba Dichondrae Repentis 8-12 part, Herba Cardiospermi microcarpi 4-8 part, Herba Ipomoeae Pes-Capraes 4-8 part, Sucus Viticis cannabifolia 3-7 part.
2. a kind of method of preventing anthraco-silicosis as claimed in claim 1, is characterized in that described Chinese medicine decoction of preventing and treating anthraco-silicosis is made up of the Chinese medicine of following weight portion: Herba Ophioglossi 9 parts, Herba Cirrohopetali Andersonii 9 parts, Ligularia nelumbifolia(Bur. et Franch.) Hand.-Mazz. 7 parts, Radix indigoferae Pseudotinctoriae 7 parts, Folium Mahoniae 10 parts, Herba Zornia Diphyllae 10 parts, Herba Gynostemmatis 10 parts, Radix Schefflerae Arboricolae (Caulis et Folium Schefflerae Arboricolae) 10 parts, Herba Dichondrae Repentis 10 parts, Herba Cardiospermi microcarpi 6 parts, Herba Ipomoeae Pes-Capraes 6 parts, Sucus Viticis cannabifolia 5 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510564128.5A CN105079479A (en) | 2015-09-01 | 2015-09-01 | Method for preventing silicosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510564128.5A CN105079479A (en) | 2015-09-01 | 2015-09-01 | Method for preventing silicosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105079479A true CN105079479A (en) | 2015-11-25 |
Family
ID=54561401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510564128.5A Pending CN105079479A (en) | 2015-09-01 | 2015-09-01 | Method for preventing silicosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105079479A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421384A (en) * | 2016-09-29 | 2017-02-22 | 广西大学 | Traditional Chinese medicinal preparation for treating senile chronic bronchitis |
| RU2611935C1 (en) * | 2016-01-29 | 2017-03-01 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний" | Method for preventing anthracosilicosis in modelling in experiment |
| US11364255B2 (en) | 2020-07-01 | 2022-06-21 | Karallief, Inc. | Therapeutic herbal compositions for improving joint health |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515304A (en) * | 2003-08-31 | 2004-07-28 | 陈长安 | Specific Chinese medicine preparation for curing pneumocoiosis and tuberculosis |
| CN101884731A (en) * | 2009-05-14 | 2010-11-17 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating silicosis |
| CN103784814A (en) * | 2014-02-18 | 2014-05-14 | 陈艳霞 | Medicinal composition for preventing and treating dust phthisis |
-
2015
- 2015-09-01 CN CN201510564128.5A patent/CN105079479A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1515304A (en) * | 2003-08-31 | 2004-07-28 | 陈长安 | Specific Chinese medicine preparation for curing pneumocoiosis and tuberculosis |
| CN101884731A (en) * | 2009-05-14 | 2010-11-17 | 北京绿源求证科技发展有限责任公司 | Traditional Chinese medicine for treating silicosis |
| CN103784814A (en) * | 2014-02-18 | 2014-05-14 | 陈艳霞 | Medicinal composition for preventing and treating dust phthisis |
Non-Patent Citations (1)
| Title |
|---|
| 王璟璠等: "尘肺及并发肺心病的中医治疗概况", 《中国现代医生》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2611935C1 (en) * | 2016-01-29 | 2017-03-01 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт комплексных проблем гигиены и профессиональных заболеваний" | Method for preventing anthracosilicosis in modelling in experiment |
| CN106421384A (en) * | 2016-09-29 | 2017-02-22 | 广西大学 | Traditional Chinese medicinal preparation for treating senile chronic bronchitis |
| US11364255B2 (en) | 2020-07-01 | 2022-06-21 | Karallief, Inc. | Therapeutic herbal compositions for improving joint health |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103961533B (en) | Traditional Chinese medicine atomizing agent for treating pharyngitis | |
| CN105079479A (en) | Method for preventing silicosis | |
| CN103169754B (en) | Traditional Chinese medicinal composition for treating asthma | |
| CN103638488B (en) | One treats pleuritic Chinese medicine composition | |
| CN102600360A (en) | Chinese medicinal preparation for treating chronic obstructive pulmonary disease with symptoms of Qi deficiency and blood stasis | |
| CN105250843A (en) | Medicament for treating cough due to wind-heat evil | |
| CN104721665A (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN103463376B (en) | Chinese herbal preparation for treating children chronic cough | |
| CN102552686A (en) | Traditional Chinese medicinal aerosol for treating chronic pharyngitis in clinical care | |
| CN106138279A (en) | Pharmaceutical composition for the treatment of rhinitis and preparation method thereof | |
| CN103417809A (en) | TCM preparation for treatment of thrush in infants and children | |
| CN103638189B (en) | The Chinese medicine preparation for the treatment of acute pharyngitis | |
| CN105327130A (en) | Traditional Chinese medicine composition for treating upper airway cough syndromes and nursing method | |
| CN105214014A (en) | A kind of medicine being used for the treatment of chronic pharyngitis | |
| CN102813864B (en) | Traditional Chinese medicine used for treating infantile cough by using roughhaired holly root | |
| CN103877379A (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis | |
| CN103536821B (en) | A kind of Chinese patent pills for the treatment of chronic rhinitis | |
| CN104983870A (en) | Traditional Chinese medicine ointment for treating infantile thrush and preparing method thereof | |
| CN103041266B (en) | Medicine for treating pediatric postoperative pneumonia | |
| CN103041268B (en) | Medicament for treating post-traumatic pneumonia | |
| CN105616919B (en) | The Chinese medicine composition for treating chronic bronchitis | |
| CN105169353A (en) | Traditional Chinese medicine for treating secretory otitis media | |
| CN103989754A (en) | Application of wild buckwheat in preparation of medicine for reducing PM2.5 damage to human body | |
| CN103989801A (en) | Rhinitis treatment decoction | |
| CN103520525A (en) | Traditional Chinese medicine preparation for treating paediatric asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151125 |